Cargando…
Utility of a Dengue-Derived Monoclonal Antibody to Enhance Zika Infection In Vitro
Introduction: Zika virus (ZIKV) has emerged in dengue (DENV) endemic areas, where these two related flaviviruses continue to co-circulate. DENV is a complex of four serotypes and infections can progress to severe disease. It is thought that this is mediated by antibody dependent enhancement (ADE) wh...
Autores principales: | Charles, Anu Susan, Christofferson, Rebecca C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026288/ https://www.ncbi.nlm.nih.gov/pubmed/27660733 http://dx.doi.org/10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620 |
Ejemplares similares
-
Dengue virus antibodies enhance Zika virus infection
por: Paul, Lauren M, et al.
Publicado: (2016) -
Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
por: Sootichote, Rochanawan, et al.
Publicado: (2023) -
Both structure and function of human monoclonal antibodies contribute to enhancement of Zika virus infectivity in vitro
por: Li, Min, et al.
Publicado: (2017) -
Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora’s box?
por: Gunawardana, Shannon A., et al.
Publicado: (2018) -
Zika virus infection in human placental tissue explants is enhanced in the presence of dengue virus antibodies in-vitro
por: Hermanns, Kyra, et al.
Publicado: (2018)